Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Invictus MD Strategies Corp. (V:GENE)

Business Focus: Alternative Medicine

INK Edge Outlook

Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for GENE within the last 6 months
See all filings within the past 6 months

Company News

Aug 19, 2019 12:51 ET
Invictus MD Strategies Corp. Opens the Market
TORONTO, Aug. 19, 2019 /CNW/ - Trevor Dixon, Chief Executive Officer, Invictus MD Strategies Corp. (GENE), joined Steven Mills, Head, Company Services, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Invictus MD Strategies Corp. is a global cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the Company's medical clients and retail customers. Invictus MD Strategies Corp. commenced trading on TSX Venture Exchange on March 31, 2017.
Read full article
Aug 14, 2019 09:00 ET
Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“Acreage”),...
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Aug 15, 201949,28814,336
Jul 31, 201934,952-8,873
Jul 15, 201943,825-67,369
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Invictus MD Strategies Corp is Canada-based company engaged in the field of alternative medicine. The Company is focused on two main verticals within the Canadian cannabis sector: Licensed Producers and AB Laboratories Inc. The Licensed Producers vertical, which is under the Access to Cannabis for Medical Purposes (ACMPR), comprises investment in Acreage Pharms Ltd, located in West-Central Alberta; AB Laboratories Inc vertical comprises investment in AB Laboratories Inc, located near Hamilton, Ontario, which has both its cultivation and sales license under ACMPR. Also, the Company is a main shareholder for Future Harvest Development Ltd, a fertilizer and nutrients manufacturer based in Kelowna, British Columbia.

See business summary

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).


Search (past week) for $GENE.CA GENE.V